Altimmune Inc. (NASDAQ:ALT)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for ALT
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- woodman: $ALT crazy moves higher. Too hot to touch.
- joelsg1: @woodman $ALT Agree. Last owned this at $16 1 year ago when RSI at about same level, down from there, although last 2 days volume impressive.
- woodman: @joelsg1 $ALT -further indication of how coo-coo for coca puffs everyone is for obesity drug candidates. I don't even know how it stacks up to the existing approved ones or if theirs is an oral version to differentiate.
- Bridgemate: @woodman $VKTX $ALT $GPCR $TERN $ALT !!! Thank you!
- Bridgemate: @curtis $SN $ALT. Thank you!
- curtis: $ALT limit order small filled at 4.22
- curtis: @woodman $VKTX (What are your thoughts on $ALT).
- woodman: @curtis $VKTX $ALT - I haven't been following ALT, but I believe it dropped hard over the summer on its reporting of obesity drug data associated with gastrointestinal issues - vomiting/nausea - which is something associated with its version hitting glucagon receptors. Personally, I'll be sticking with VKTX which is expected to have more obesity drug data 1Q24.
- curtis: @woodman $VKTX $ALT Altimmune (ALT) reported strong Phase 2 trial results for its weightloss drug. ALT soared Friday https://ir.altimmune.com/news-releases/news-release-details/altimmune-announces-positive-topline-results-momentum-48-week The data in the study does cover the withdrawl of patients in study, but those that stayed lost significant weight on a pill vs shot every month.
- woodman: @curtis $VKTX $ALT - Interesting, thanks for the info. VKTX working on a pill as well. I'll have to read up on ALT. I do believe that these baby bio obesity drug makers are attractive to BP that want a slice of the obesity pie, and we'll continue to see acquisitions in the area.
- woodman: @curtis $VKTX $ALT - I just saw this: "HC Wainwright reissued their buy rating on shares of Altimmune (NASDAQ:ALT) in a report issued on Friday, Benzinga reports. The brokerage currently has a $15.00 price objective on the stock." And here is the full link to ALT's press release. https://ir.altimmune.com/news-releases/news-release-details/altimmune-announces-positive-topline-results-momentum-48-week
- curtis: @woodman $VKTX (Sold $ALT at $5).
- woodman: @curtis $VKTX $ALT - One other thing, if you're looking for a similar pop on obesity data reporting, I believe the only ones in the obesity TA that are reporting data next year are $VKTX $TERN and $GPCR. I believe $VKTX is 1Q24. I need to check on all of that. I think $VKTX offers a good opportunity if I am correct about 1Q24.
- woodman: @curtis $VKTX $ALT - Nice. I added some info in our thread below about which ones are next up for reporting obesity drug data (i.e. 2024). Take a look. They are good targets for data pops. I plan to get back into $VKTX for its expeced 1Q24 data reporting.
- joelsg1: @woodman $VKTX $ALT $GPCR working, now above water and added. Roche bought privately held Carmot for $2.7B. $GPCR same potential.
- woodman: @joelsg1 $VKTX $ALT $GPCR - Yep. I mentioned the buyout below and that it applies to the space broadly, IMO. It's a big pie and BP wants in. The assets are with the baby bios - As I mentioned - $VKTX $TERN and $GPCR all have more data coming in 2024.
- joelsg1: $VKTX Sold remainder first thing am, seen this movie before with $ALT.
- woodman: @joelsg1 $VKTX $ALT - I'm with you. I have only a small reminder position in VKTX as well. It's all about $LLY's obesity drug. Even $PFE out of favor now that it ditched one of its treatments in favor of a two a day pill, but is far behind on a one a ...
- joelsg1: @woodman $VKTX $ALT $LLY $PFE $TERN Following your lead on these, but obvious concern that the Big Boys' oral formulations will swamp little guys like $VKTX. Also concerned about the thyroid cancer risks being studied, where hopefully $VKTX may have better profile.
- woodman: @joelsg1 $VKTX $ALT $LLY $PFE $TERN - Very valid concerns. And the small guys are years away. Perhaps a PFE type scoops one of them up in time. Not holding my breath. The need more data.
- woodman: @joelsg1 $VKTX $ALT $LLY $PFE $TERN - VKTX looks destined for the 11s-12s.
- phgruver: @woodman $VKTX $ALT $LLY $PFE $TERN $PFE has been in a downtrend for over a year, peaking in Dec 2021. Part of this mimics the market, but the past 6 months, $PFE has definitely under performed. At the current price, the $.41/qtr dividend produces a 4.45% return, something to consider for income in a LT account. As one of the big dogs in that space, I would consider adding, cautiously, to $PFE as a #VALUE play.
- joelsg1: @woodman $VKTX $ARDX Cautionary tale perhaps, $ALT.
- woodman: @joelsg1 $VKTX $ARDX $ALT - That crossed my mind too, but ALT and VKTX have a different compound/component at play which many believe significantly differentiates the two and leads many to believe the result will different in terms of Adverse Events (and perhaps efficacy as well?) - they believe VKTX won't have those AEs to significant degree. That said, it may cause people not to take the chance into the data.
- mharps: $ALT cooking
- mharps: $ALT small starter
- bigreek42: $alt looking perky
- setshot: Dan indicated an alert for $ALT on Aug 12 at 18.50. It just broke that price if anyone is interested.
- fiebs: $ALT breaking out of a squeeze
- fiebs: @fiebs $ALT A rocket this morning. Up 28%
-
DAN: ...
$ALT -- Squeeze breakout today. @fiebs posted this at 9:45. Plenty of time to catch a big move! Thanks!! Alert $18.50
$BEAM
Semis ($SMH)
$NVDA
$ON -- @Scottrades has been all over this.
$ARKK
$DNA
$HOOD -- Watch for breakout above $11.34. Alert ... - slp20:
- Fredjo: Stocks on my watchlist for a swing trade : $ALT - good volume , close above MA50 & 8EMA crossover with 50MA $DBX - good volume , close above MA50 and 8 EMA crossover $AI
- joelsg1: $ALT Up 5% ah after announcing Phase 1 data release tomorrow before open from anti- obesity drug trial. Long for a loss, so far.
- BellaVino: @joelsg1 $ALT Anti-obesity drug? Long gone is functional medicine - there's no money in that!
- Mnatale: @AdrenalineTrade $ANY If only $ALT could break this 16$ range, even with the upgrade it seems slow.
- AdrenalineTrade: @Mnatale $ANY $ALT That line is straight up algo buying. Stay with it til it ends.
- joelsg1: $ALT Target increase to $27 B. Riley, expecting additional data on Phase 1 weight loss drug later in September. However, these guys are serial disappointers. Still, spec. long.
- bRobert: @joelsg1 $ALT Speed bump here PULLBACKS
- joelsg1: @bRobert $ALT Noted, 2x in 2 months after failure of nasal Covid vaccine so pb expected.
- bRobert: @joelsg1 $ALT Just up at resistance Flag
- jfd: @bRobert $NAIL $ALT Do you like this ticker anymore? great contributions to the forum !
- bRobert: @jfd $NAIL $ALT I own a SPEC sized. piece of. ALT. $ALT. potential WEEKLY Speed. bump. here. Pullbacks to add.
- jfd: @bRobert $NAIL $ALT thank you.
- joelsg1: @bRobert $NAIL $ALT Still holding some $ALT as well, partial profited out before they ended their Covid nasal vaccine trial, but spec holding for their anti obesity drug.
- Mnatale: @bRobert $NAIL $HD having you been looking at $ALT? coming back from that COVID drop disaster.
- bRobert: @Mnatale $NAIL $HD $ALT I peek. too many specs It will fill gap to $16
- AdrenalineTrade: $ALT small position at 11.22, gap filled on daily
- AdrenalineTrade: $ALT buyers stepping up nicely
- Mnatale: $ALT-@brobert- remember this one? Well its perking up again after earnings
- Motorman: @bRobert $NVAX Though ahead of $ALT in development, still gives me butterfly's RE: still no product yet, not even Nano Flu.
- humble: $ALT Whats the news on $ALT down 36+% ???
- Yes-Man: @humble $ALT Clinical trial failed!! Bio tech!
- joelsg1: @Hawaiianmaxx $ABT $ALT .
- Pokersmith: @joelsg1 $ABT $ALT case in point 😉
- bsnceo: $ALT moving up nicely
- bRobert: @bsnceo $ALT OVERWEIGHT this spec HIGH TARGET POTENTIAL $20/$35+
- bsnceo: @bRobert $ALT I am overweight on $ALT as well.
- bRobert: $NNDM Breakout Pullback from $9.30 speed bump/ retest...............bounce Well behaved $ALT doing nothing wrong Speed bump at $17 pullback Flag still intact May touch the 20d if longer sideways $PTON Breakout Not much of a pullback .......bounce Moving through speed bumps $170 potential with this reversal base
- Mnatale: anyone else's system Halt $ALT with ETrade ( shares halted pending news material)
- Mikev200: @Mnatale $ALT Yes HALTED
- Mikev200: @Mnatale $ALT Altimmune discontinuing further development of AdCOVID beyond completion of Phase 1 trial; shares are halted
- Crodmm: @Mnatale $ALT there is a Halt banner on the CNBC app
- Mnatale: @Crodmm $ALT- worst nightmare right here.. not sure if I should sell or hold.
- bRobert: @Mnatale $ALT Spec Positions should be small relative to other positions in your portfolio They are riskier trades so small works best We road this one from single digits to $35 last year
- Henry: @Mnatale $ALT Bookmark this page http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
- Pokersmith: @Mnatale $ALT I see a low of 9.19 in A.H's on Fidelity np
- joelsg1: @bRobert $ALT That’s 2 biotechs with failed trials for me this week. $EXEL too.
- Mnatale: @Henry $ALT looked at this right after it was halted..
- debeers: $ALT-NO POSITION- stock is no longer halted but now you see what can happen in a biotech when the research doesn't pan out: stock closed at 15.90 and last trade was 10.82.DOWN 31.13%
- joelsg1: @debeers $ALT Unfortunate, but they have a more promising anti obesity drug in trials, so think this bounces. Too bad for the World that they’re giving up on the nasal vaccine platform.
- Mnatale: @debeers $ALT worst is, I got out this morning and then back in this afternoon... kicking myself, taking my fur babies for a walk. Peace out.
- bRobert: @joelsg1 $ALT $EXEL In biotech I primarily use indexes to sidestep headline risk Few exceptions A bad headline can cut a stock in half
- bRobert: @joelsg1 $ALT Failed badly with the flu vaccine
- Henry: @debeers $ALT Henry when he used to trade biotech stocks
- Pokersmith: @bRobert $ALT $EXEL Same here...sometimes , just the word "Bio" in the name is enough of a reason for me to pan it. I'll only play an ETF for the most part.
- joelsg1: @bRobert $ALT Third time charm?
- bRobert: @joelsg1 $ALT Buy more nvda on pullback bounces
- seank: @Mnatale $ALT Whew! I got stopped out this morning but did NOT get back in. Glad to have been lucky on a short-term trade.
- issues: $AVXL a biotec that coming in for a landing. Still holding but nervously! We also have $BNTX and put in a 'limit order' for $SAVA. I like the wedge pattern that's forming. NP on $ALT - thankfully!
- bRobert: $BILI WEEKLY 5/13 cross in motion $155 $BIDU Long for a few weeks HIGH potential $220 - $260+ Potential Early Pullback bounces $FXI inv H&S $CCIV WEEKLY 5/13 in motion $38 potential $PLUG $50 $NNDM WEEKLY 5/13 pending Big WEEKLY base 200d target $12 HIGHER when cleared MUCH $DDD $50 Shorts $LMND watching with partial WEEkLY 5/13 cross High short int $TAN Look for move > 200d Alpha dogs $RUN $ENPH $SEDG $SPWR $FSLR $100 $SOL spec $JKS Pullback bounces Missed this I thought it would move Solar and perky $FXI $HD $320 - $380 $ITB $NAIL $LEN $110 reversal bases awaiting triggers $LAD $450/$500 potential Pullback bounces $VRM $54 - $70 $100 long term $CVNA WEEKLY base Shorts Retest pullback............ $AN $KMX reversals $ALGN $750 - $1000 WEEKLY base $ALT WATCH IT $BNGO Low risk High reward on pullback Shorts $MED Buy a flag trigger $350 potential WEEKLY the chart ZIG
- bRobert: $ALT Take a small piece Working its way above 200week $22/$35+ potential SPEC $VRXT another Daily Wedge Very high potetnial Shorts for both SPECS
- Trendrider: @bRobert $ALT $VRXT You mean $VXRT
- bRobert: @bRobert $ALT $VRXT $VXRT
- bRobert: $ALT. $VXRT. Specs with huge upside. WEEKLY. 5/13 crosses. WEDGES with top of the chart potential Just a small piece. works.
- Mnatale: @brobert-watching $ALT
- bRobert: @Mnatale $ALT yes. long. Added yesterday
- bRobert: $TSLA. $720. TARGET To start Long call spreads $ARKK WEEKLY 5/13 cross. Long calls. Easy to follow. one chart /etf of alpha dogs $QCOM. coiled/pinch. daily WEEKLY Ready to move Here comes the sun trade. continues. Any one will work. or. $TAN $ENPH $SPWR. $SEDG. alpha dogs $ALT. $20 in a blink potential. with move. over 200W $CCIV. $PLUG. continuation/reversals $XOP. $125/$150+ Long leaps Any XOP. related will work $HD. reversal. Fresh 5/13 daily. cross. $330 - $380. potential. Look for. $ITB. related to follow $Z. is gonna move. Looking for a pop High shorts $LABU. flag over the 50d. $85/$110. potential. Alerts $MED. Own a piece. WEEKLY. zig $400 . potentiaL $BIDU. INTERESTING. Bounce off 50/200W. Daily rounding bottom. Tight consolidation could pop over the 50/200d close by and begin a nice uptrend. EARLY $NNDM. $9.3/$11.5. $DDD. $47 . High. base/flag
- Wykeman: @bRobert $TSLA $ARKK $QCOM $TAN $ENPH $SPWR $SEDG $ALT $CCIV $PLUG $XOP $HD $ITB $Z $LABU $MED $BIDU $NNDM $DDD $NVCR looks to open at NH. Nice
- bRobert: @Wykeman $TSLA $ARKK $QCOM $TAN $ENPH $SPWR $SEDG $ALT $CCIV $PLUG $XOP $HD $ITB $Z $LABU $MED $BIDU $NNDM $DDD $NVCR $NVCR. $300. potential. WEEKLY. base. Long
- bRobert: $ALT small add
- bRobert: $ALT. baby steps. Higher low. Looking for a higher. high Shorts
- joelsg1: @bRobert $VXRT Clockwork Orange trade for me, in/out. My chemist son is not a believer in a pill getting past stomach acid as vaccine to provoke immune response, prefers $ALT nasal spray.
- bRobert: $ALT. multi day. C&H.
- bRobert: $ALT. Watch for. move. back. > 200 Week. and a run towards. $20
- bRobert: $ALT. moving
- Bwhitty: $ALT 4 days of short interest. I have stock and some 20 strike calls.
- Hawaiianmaxx: @Bwhitty $ALT hey what did marketsmith say about the short interest thing you guys w were talking about?
- Bwhitty: @Hawaiianmaxx $ALT I know Scott uses marketsmith but I don't as much. Probably should.
- Hawaiianmaxx: @Bwhitty $ALT Ahh my bad must've been another member 😅
| Stock Price | $7.26 |
| Change | 0.83% |
| Volume | 2,250,670 |
The investment seeks to maximize absolute returns. The fund seeks to achieve its objective by investing in a portfolio of foreign currency forward contracts and exchange-traded futures contracts that may involve commodities, currencies, interest rates and certain eligible stock or bond indices while seeking to reduce the risks and volatility inherent in those investments by taking long and short positions in historically correlated assets.
Request Video of ALTAlready a member? Sign in here.
Past Month
Leading Peers
Past Month
Lagging Peers
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!